Stream every public session from the 27th annual Global Conference right here on our website.

Watch Here
results for:

Content Type

Centers and Programs

Topics

Tags

Refine by Date

8
Part 1: FasterCures: Accelerating the Future of Health panel
Part 1: FasterCures: Accelerating the Future of Health
To mark the occasion of FasterCures entering its third decade, join the organization’s current a
nd founding leadership to take a look back at how far medical research has advanced
May 1, 2023
FasterCures Quarterly Update: July 2023 article
FasterCures Quarterly Update: July 2023
In This Issue: Convenings Recap Policy Updates FasterCures in the Media FasterCures in the Communit
y
Jul 13, 2023
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief report
Pandemic and All-Hazards Preparedness Act (PAHPA) Policy Brief
The Milken Institute Center for Public Health and FasterCures have identified three PAHPA 2023 poli
cy priorities that are core to improving and strengthening the nation’s biosecurity and preparedness infrastructure.
Jul 21, 2023
Statement at Multi-Stakeholder meeting in support of the UN High-Level Meeting on Pandemic Prevention, Preparedness and Response article
Statement at Multi-Stakeholder meeting in support of the UN High-Level Meeting on Pandemic Prevention, Preparedness and Response
FasterCures would like to express our strong support for current initiatives to advance pandemic pre
vention, preparedness, and response. We appreciate the opportunity to provide our perspective in these critical discussions.
May 9, 2023
National Institutes of Health (NIH) Director Nomination article
National Institutes of Health (NIH) Director Nomination
Esther Krofah Executive Vice President, Health Executive Director, FasterCures and Center for Public
Health   Milken Institute
May 15, 2023
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870 article
Comments on FDA’s Draft Guidance for Industry, Investigators, and Other Stakeholders on Decentralized Clinical Trials for Drugs, Biological Products, and Devices - Docket ID FDA-2022-D-2870
Submitted electronically Dr. Robert Califf Commissioner US Food and Drug Administration Silver Spri
ng, MD 20993 Dear Dr. Califf,
Jul 31, 2023
Request for Information: Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials, NIH RFI Notice Number NOT-TR-23-006 article
Request for Information: Advancing Clinical and Translational Science through Accelerating the Decentralization of Clinical Trials, NIH RFI Notice Number NOT-TR-23-006
Submitted electronically Joni Rutter, Ph.D. National Center for Advancing Translational Sciences Na
tional Institutes of Health 6701 Democracy Blvd Bethesda, MD 20892-4874 Dear Director Rutter,
May 12, 2023
Discussion Draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization article
Discussion Draft of the Pandemic and All-Hazards Preparedness Act (PAHPA) Reauthorization
Submitted electronically 
Jul 10, 2023